201 related articles for article (PubMed ID: 18259703)
1. Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab.
Bölke E; Gerber PA; Lammering G; Peiper M; Müller-Homey A; Pape H; Giro C; Matuschek C; Bruch-Gerharz D; Hoffmann TK; Gripp S; Homey B; Budach W
Strahlenther Onkol; 2008 Feb; 184(2):105-10. PubMed ID: 18259703
[TBL] [Abstract][Full Text] [Related]
2. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.
Giro C; Berger B; Bölke E; Ciernik IF; Duprez F; Locati L; Maillard S; Ozsahin M; Pfeffer R; Robertson AG; Langendijk JA; Budach W
Radiother Oncol; 2009 Feb; 90(2):166-71. PubMed ID: 18977050
[TBL] [Abstract][Full Text] [Related]
3. Severe radiation dermatitis in patients with locally advanced head and neck cancer treated with concurrent radiation and cetuximab.
Koutcher LD; Wolden S; Lee N
Am J Clin Oncol; 2009 Oct; 32(5):472-6. PubMed ID: 19487913
[TBL] [Abstract][Full Text] [Related]
4. Severe cutaneous reaction during radiation therapy with concurrent cetuximab.
Budach W; Bölke E; Homey B
N Engl J Med; 2007 Aug; 357(5):514-5. PubMed ID: 17671265
[No Abstract] [Full Text] [Related]
5. Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.
Studer G; Brown M; Salgueiro EB; Schmückle H; Romancuk N; Winkler G; Lee SJ; Sträuli A; Kissling B; Dummer R; Glanzmann C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):110-7. PubMed ID: 20732757
[TBL] [Abstract][Full Text] [Related]
6. More on severe cutaneous reaction with radiotherapy and cetuximab.
Bonner JA; Ang K
N Engl J Med; 2007 Nov; 357(18):1872-3; author reply 1873. PubMed ID: 17978301
[No Abstract] [Full Text] [Related]
7. Management of dermatitis in patients with locally advanced squamous cell carcinoma of the head and neck receiving cetuximab and radiotherapy.
Cabezón-Gutiérrez L; Khosravi-Shahi P; Escobar-Álvarez Y
Oral Oncol; 2012 Apr; 48(4):293-7. PubMed ID: 22137799
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy combined with cetuximab for locally advanced head and neck cancer: results and toxicity.
Acevedo-Henao CM; Valette G; Miglierini P; Lefur E; Pradier O
Cancer Radiother; 2012 Oct; 16(7):601-3. PubMed ID: 23089070
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic image; a man with severe radiation dermatitis].
Janssens GO; van Herpen CM
Ned Tijdschr Geneeskd; 2009; 153():B413. PubMed ID: 19785863
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis.
Birnbaum A; Dipetrillo T; Rathore R; Anderson E; Wanebo H; Puthwala Y; Joyce D; Safran H; Henderson D; Kennedy T; Ready N; Sio TT
Am J Clin Oncol; 2010 Apr; 33(2):144-7. PubMed ID: 19786848
[TBL] [Abstract][Full Text] [Related]
11. Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines.
Bernier J; Russi EG; Homey B; Merlano MC; Mesía R; Peyrade F; Budach W
Ann Oncol; 2011 Oct; 22(10):2191-200. PubMed ID: 21606209
[TBL] [Abstract][Full Text] [Related]
12. Radiochemotherapy with cetuximab, cisplatin, and amifostine for locally advanced head and neck cancer: a feasibility study.
Koukourakis MI; Tsoutsou PG; Karpouzis A; Tsiarkatsi M; Karapantzos I; Daniilidis V; Kouskoukis C
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):9-15. PubMed ID: 19744802
[TBL] [Abstract][Full Text] [Related]
13. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer.
Pryor DI; Porceddu SV; Burmeister BH; Guminski A; Thomson DB; Shepherdson K; Poulsen M
Radiother Oncol; 2009 Feb; 90(2):172-6. PubMed ID: 18976827
[TBL] [Abstract][Full Text] [Related]
14. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck.
Bernier J; Bonner J; Vermorken JB; Bensadoun RJ; Dummer R; Giralt J; Kornek G; Hartley A; Mesia R; Robert C; Segaert S; Ang KK
Ann Oncol; 2008 Jan; 19(1):142-9. PubMed ID: 17785763
[TBL] [Abstract][Full Text] [Related]
15. Severe cutaneous toxicity during concomitant radiotherapy and cetuximab treatment of head and neck cancer.
Vano-Galvan S; de las Heras E; Harto A; Jaen P
Eur J Dermatol; 2008; 18(4):471-2. PubMed ID: 18573734
[No Abstract] [Full Text] [Related]
16. Treatment of head and neck cancers: issues for clinical pharmacists.
Scarpace SL; Brodzik FA; Mehdi S; Belgam R
Pharmacotherapy; 2009 May; 29(5):578-92. PubMed ID: 19397465
[TBL] [Abstract][Full Text] [Related]
17. Cetuximab-induced cutaneous toxicity.
Tomková H; Kohoutek M; Zábojníková M; Pospísková M; Ostrízková L; Gharibyar M
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):692-6. PubMed ID: 19925598
[TBL] [Abstract][Full Text] [Related]
18. Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab.
Selzer E; Liederer S; Lemaire C; Kren G; Radonjic D; Kornek G; Knocke T; Pötter R; Bachtiary B
Strahlenther Onkol; 2011 Jun; 187(6):373-7. PubMed ID: 21603990
[TBL] [Abstract][Full Text] [Related]
19. Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer.
Kao J; Genden EM; Gupta V; Policarpio EL; Burri RJ; Rivera M; Gurudutt V; Som PM; Teng M; Packer SH
Cancer; 2011 Jan; 117(2):318-26. PubMed ID: 20830768
[TBL] [Abstract][Full Text] [Related]
20. Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma.
Pryor DI; Burmeister E; Burmeister BH; Poulsen MG; Porceddu SV
Oral Oncol; 2011 Oct; 47(10):984-7. PubMed ID: 21852185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
